Valerio Zoli
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma: Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study).
Journal: Hematological oncology
Published: March 13, 2022
Resolution of primary hepatic marginal zone lymphoma in a hepatitis C virus-infected patient treated with a direct-acting antiviral.
Journal: Oxford medical case reports
Published: October 19, 2020
Treatment and prognosis of primary pulmonary lymphoma: A long-term follow-up study.
Journal: European journal of haematology
Published: June 23, 2020
The neutrophil to lymphocyte ratio (NLR) and the presence of large nodal mass are independent predictors of early response: A subanalysis of the prospective phase II PET-2-adapted HD0607 trial.
Journal: Cancer medicine
Published: April 03, 2020
Antiviral therapy in hepatitis C-infected patients prevents relapse of diffuse large B cell lymphoma.
Journal: Clinical and experimental hepatology
Published: May 14, 2018
Aggressive lymphomas of the elderly: the DEVEC metronomic chemotherapy schedule fits the unfit.
Journal: British journal of haematology
Published: December 02, 2017
Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell Lymphomas.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 16, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026